KF

Karen Ferrante

OP Osi Pharmaceuticals: 2 patents #70 of 181Top 40%
TP Tokai Pharmaceuticals: 2 patents #2 of 8Top 25%
UB University Of Maryland, Baltimore: 2 patents #236 of 1,115Top 25%
UW University Of Washington: 2 patents #544 of 2,234Top 25%
📍 Boston, MA: #1,707 of 5,993 inventorsTop 30%
🗺 Massachusetts: #27,608 of 88,656 inventorsTop 35%
Overall (All Time): #1,199,316 of 4,157,543Top 30%
4
Patents All Time

Issued Patents All Time

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
9808472 Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies Vincent C. O. Njar, Amina Zoubeidi, Eva Corey, Douglas B. Jacoby 2017-11-07
9387216 Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies Vincent C. O. Njar, Amina Zoubeidi, Eva Corey, Douglas B. Jacoby 2016-07-12
7087613 Treating abnormal cell growth with a stable polymorph of N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride Timothy Norris, Jeffrey W. Raggon, Richard Connell, James D. Moyer, Michael John MORIN +3 more 2006-08-08
6900221 Stable polymorph on N-(3-ethynylphenyl)-6, 7-bis (2methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof Timothy Norris, Jeffrey W. Raggon, Richard Connell, James D. Moyer, Michael John MORIN +3 more 2005-05-31